Genelink Inc (GNLKQ)
0.00
USD |
OTCM |
Nov 13, 16:00
Genelink 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
February 20, 2024 | 0.00% |
February 16, 2024 | 0.00% |
February 15, 2024 | 0.00% |
February 14, 2024 | 0.00% |
February 13, 2024 | 0.00% |
February 12, 2024 | 0.00% |
February 09, 2024 | 0.00% |
February 08, 2024 | 0.00% |
February 07, 2024 | 0.00% |
February 06, 2024 | 0.00% |
February 05, 2024 | 0.00% |
February 02, 2024 | 0.00% |
February 01, 2024 | 0.00% |
January 31, 2024 | 0.00% |
January 30, 2024 | 0.00% |
January 29, 2024 | 0.00% |
January 26, 2024 | 0.00% |
January 25, 2024 | 0.00% |
January 24, 2024 | 0.00% |
January 23, 2024 | 0.00% |
January 22, 2024 | 0.00% |
January 19, 2024 | 0.00% |
December 22, 2023 | 0.00% |
December 21, 2023 | -99.00% |
December 20, 2023 | -99.00% |
Date | Value |
---|---|
December 19, 2023 | -99.00% |
December 18, 2023 | -99.00% |
December 15, 2023 | -99.00% |
December 14, 2023 | -99.00% |
December 13, 2023 | -99.00% |
December 12, 2023 | -99.00% |
December 11, 2023 | -99.00% |
December 08, 2023 | -99.00% |
December 07, 2023 | -99.00% |
December 06, 2023 | -99.00% |
December 05, 2023 | -99.00% |
December 04, 2023 | -99.00% |
December 01, 2023 | -99.00% |
November 30, 2023 | -99.00% |
November 29, 2023 | -99.00% |
November 28, 2023 | -99.00% |
November 27, 2023 | -99.00% |
November 24, 2023 | -99.00% |
November 22, 2023 | -99.00% |
November 21, 2023 | -99.00% |
November 20, 2023 | -99.00% |
November 17, 2023 | -99.00% |
November 16, 2023 | -99.00% |
November 15, 2023 | -99.00% |
November 14, 2023 | -99.00% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.99%
Minimum
Mar 01 2022
2.53K%
Maximum
Mar 01 2021
65.07%
Average
-20.63%
Median
Sep 17 2020
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -74.28% |
AIM ImmunoTech Inc | -44.75% |
IGC Pharma Inc | 19.61% |
NovaBay Pharmaceuticals Inc | -93.43% |
Protalix BioTherapeutics Inc | -8.15% |